Achaogen Receives Mixed Update From FDA
Achaogen shares were crumbling on Tuesday following some mixed news from the FDA regarding its treatment of urinary tract and bloodstream infections.
All Work
Chris Lange
Is This the Turnaround That Achieve Life Sciences Has Waited For?
Achieve Life Sciences saw its shares skyrocket on Tuesday after the company announced positive results from its smoking cessation study.
Why Infinity Pharma Shares Are Booming
Infinity Pharmaceuticals shares made a healthy gain early on Tuesday after the firm announced a clinical collaboration with Arcus Biosciences.
Wells Fargo Settles More of Its Charges With the SEC
Wells Fargo has settled more of its charges with the SEC. This is yet another offense by the mega bank that is being added a growing list of things to apologize for.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a down day for the broad U.S. markets with each of the major exchanges dropping over 1% on the day. The Nasdaq was the worst of the group reaching below 2% to…
What to Expect When Nike Reports Thursday
Anticipation seems to be building ahead of Nike's fourth-quarter report, as one key analyst already has come out with a glowing recommendation for the stock.
Kraft Rumored to Be Hungry for Campbell Soup
Campbell Soup shares saw a solid gain in Monday’s session after it was reported that Kraft Heinz may be looking to gobble up the soup maker.
Why Carnival Is Monday’s Big Earnings Loser
Carnival released better-than-expected fiscal second-quarter financial results but disappointing guidance early on Monday.
Why Merrimack Pharmaceuticals Is Getting Crushed
Merrimack Pharmaceuticals shares were absolutely getting crushed on Monday after the firm gave an update from its midstage pancreatic cancer study.
AT&T Moves to Acquire AppNexus
This proposed acquisition of AppNexus would help AT&T accelerate the growth of its advertising platform and broaden its footprint globally.
Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer
Pfizer shares slipped slightly on Monday morning after the firm announced results from its late-stage trial of breast cancer. Ultimately the results were positive but not exactly what the study was looking for.
Nike, Walgreens, Rite Aid and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Nike, Rite Aid, Walgreens and some of the other top companies reporting their latest results in the coming week.
Biopharma Companies to Watch This Week
Here, 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a positive day for the broad U.S. markets. Although the Nasdaq was relatively flat both the Dow and S&P 500 recovered handily from Thursday. Crude oil was perhaps the biggest winner in…
Why CarMax Is Friday’s Big Earnings Winner
CarMax released better-than-expected fiscal first-quarter financial results before the markets opened on Friday.
Tandem Diabetes Keeps Rolling Out the Hits
Tandem Diabetes Care shares made a solid gain early on Friday after the firm announced a key approval from the FDA.
Should BlackBerry Be Getting More Credit for This Quarter?
BlackBerry reported better-than-expected fiscal first-quarter financial results before the markets opened on Friday
Why Red Hat Is Sinking Despite a Solid Q1
Red Hat released better-than-expected fiscal first-quarter financial results before the markets opened on Friday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday started out as a down day for the broad U.S. markets and only got worse from there. The S&P 500 and Nasdaq pulled back even further from their highs. Crude oil more or…
Tilray Files for IPO
This company is pioneering the future of medical cannabis research, cultivation, processing and distribution globally, and it intends to become a leader in the adult-use cannabis market in Canada once legalized later this year.